|
|
| Médicaments En Vente Libre > Etude de marché sectorielle |
| Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies |
|
|
|
|
€ 2 443,75 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Janvier 2005 |
Taille du document : |
146 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
US Laxatives 2004
12 pages | Novembre 2004 |
Snapdata's US Laxatives 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US laxative market, and covers laxat |
240,00 €
|
| |
| |
Poland OTC Pharmaceuticals 2004
11 pages | Juillet 2004 |
Snapdata's Poland OTC Pharmaceuticals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the Polish OTC pharmaceuti |
240,00 €
|
| |
| |
US Hair Growth Products 2004
12 pages | Juillet 2004 |
Snapdata's US Hair Growth Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US hair growth product ma |
240,00 €
|
| |
| |
US Oral Pain Relief 2005
12 pages | Mars 2005 |
Snapdata's US Oral Pain Relief 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US oral pain relief market, a |
240,00 €
|
| |
| |
eCompliance - Part 2: The Physician's Perspective
84 pages | Mars 2005 |
IntroductionThe eCompliance market, though immature, is developing rapidly.
The market will continue to grow as novel means of addressing compliance issues through online channels emerge.
Long-t |
3 040,00 €
|
| |
| |
US Pregnancy & Ovulation Test Kits 2004
12 pages | Novembre 2004 |
Snapdata's US Pregnancy & Ovulation Test Kits 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US pregnancy a |
240,00 €
|
| |
| |
US Lice Treatments 2004
13 pages | Juillet 2004 |
Snapdata's US Lice Treatments 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US lice treatment market, and |
240,00 €
|
| |
| |
US Internal Analgesics 2004
14 pages | Juillet 2004 |
Snapdata's US Internal Analgesics 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US internal analgesic mark |
240,00 €
|
| |
| |
Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies
146 pages | Janvier 2005 |
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the mo |
2 443,75 €
|
| |
| |
US Vitamins & Minerals 2004
13 pages | Novembre 2004 |
Snapdata's US Vitamins & Minerals 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US vitamin and mineral mar |
240,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies |
|
|
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the most effective strategies to deliver the maximum returns from their drugs portfolio. The management report ‘Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies’, outlines key generics players and the strategies they are using to capture a larger market share of the drugs market. In Generics Defense Strategies, Peter Wittner, a generics market expert and former industry executive, analyzes the most effective legal, reformulation and marketing strategies to counteract the generic threat and details the benefits of an integrated brand defense strategy. Use this report to make certain you have selected the most suitable legal and patent strategies, formulation strategies and DTC/OTC strategies for your company in both European US markets. These strategies combined will help you build market share and enable you to extend your brand’s lifecycle.
|
|
Pressure on the pharmaceutical industry to deliver productivity, strong generics market growth as well as an unfavorable legislative environment have caused pharmaceutical companies to reassess the most effective strategies to deliver the maximum returns from their drugs portfolio. The management report ‘Generics Defense Strategies: Effective brand protection through patent, formulation, OTC and DTC strategies’, outlines key generics players and the strategies they are using to capture a larger market share of the drugs market. In Generics Defense Strategies, Peter Wittner, a generics market expert and former industry executive, analyzes the most effective legal, reformulation and marketing strategies to counteract the generic threat and details the benefits of an integrated brand defense strategy. Use this report to make certain you have selected the most suitable legal and patent strategies, formulation strategies and DTC/OTC strategies for your company in both European US markets. These strategies combined will help you build market share and enable you to extend your brand’s lifecycle.
|
|
|
PPLSEN
|
|
|
|
|
